ERBB2 and neoplasm: After engraftment of the tumor cells, freshly isolated and non-stimulated PBMCs from a healthy donor were injected i.v., followed by a saline control, the paired EGFR, and Her2/neu specific hemibodies or an EGFR-specific BiTE control, which were administered s.c. (Fig. 5c).